IDiyas

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

Perry C Heath

USPTO Granted Patents = 12

Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 157(Granted Patents)


Location History:

  • Indianapolis,, IN (US) (1996)
  • Indianapolis, IN (US) (1981 - 2007)

Company Filing History:

goldMedal12 out of 4,442 
 
Eli Lilly and Company
 patents

Years Active: 1981-2007

Loading Chart...
12 patents (USPTO):Explore Patents
1. 7160922 - Hemihydrate of a selective functional M1 muscarine receptor agonist (2007-01-09),
2. 6111110 - Synthesis of benzo[f]quinolinones (2000-08-29),
3. 5945547 - Imtermediate in process to make 2', 2'-difluoronucleosides (1999-08-31),
4. 5578720 - Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof (1996-11-26),
5. 5574160 - Syntheis of benzoquinolinones (1996-11-12),
6. 5550231 - Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof (1996-08-27),
7. 5434254 - Process for preparing 2',2'-difluoronucleosides (1995-07-18),
8. 5223608 - Process for and intermediates of 2',2'-difluoronucleosides (1993-06-29),
9. 4965374 - Process for and intermediates of 2',2'-difluoronucleosides (1990-10-23),
10. 4665168 - Cephalosporin intermediate (1987-05-12),
11. 4525587 - Process for preparing a cephalosporin compound (1985-06-25),
12. 4303591 - Removal of stannic chloride (1981-12-01),

Title: The Innovative Contributions of Perry C. Heath

Introduction

Perry C. Heath is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work focuses on developing innovative compounds that have the potential to impact medical treatments.

Latest Patents

Among his latest patents is the invention titled "Hemihydrate of a selective functional M1 muscarine receptor agonist." This invention provides crystalline biphenyl-4-carboxylic acid (R)-(6-(1-((4-fluorobenzyl)methylamino)ethylideneamino)-2(R)-hydroxyindan-1-yl)amide hemihydrate, along with compositions, methods of use, and processes for making the same, including intermediates. Another significant patent is the "Synthesis of benzo[f]quinolinones," which showcases his expertise in chemical synthesis.

Career Highlights

Perry C. Heath is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and research. His work at Eli Lilly has allowed him to contribute to various projects that aim to improve healthcare outcomes.

Collaborations

Throughout his career, Perry has collaborated with esteemed colleagues, including Ta-Sen Chou and Lawrence E. Patterson. These collaborations have fostered a productive environment for innovation and have led to the development of groundbreaking inventions.

Conclusion

Perry C. Heath's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the industry and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…